Dear customers,
together we are all facing a very challenging time caused by the COVID-19 virus. Following the governmental recommendations and advices in Germany, ac.biomed has taken responsibility and has limited the number of team members working on-site.

Due to our home-office policy, electronic communication by email is currently the preferred option.

Nevertheless, the ac.biomed team is available for you at anytime by e-mail and partially on the central phone number +49 241 942 618-0. You may also contact our customer service on the following interim number: +49 1590 4499 018. We apologize for any inconvenience caused by temporary non-availability.
Stay healthy!

Dear valued Clients,

together we are facing the most challenging time that all of us have ever seen in our business. We are all experiencing that health is a fragile good and that saving lives must be our ultimate goal.

Therefore, we are not only accepting what the WHO and national organs are requiring from us, but ac.biomed actively participates in promoting what is the best for our communities, even if it is hard for us individually.

We at ac.biomed have taken strict measures to protect our employees and their families, as well as the ones around us.

Through these measures we have ensured at the same time that we can continue to provide our most essential services to our customers.

We know that time is essential to your business and the tests or studies that you are running with us may have a huge impact on your development program and/or regulatory approval.

All services that are run in our own ISO-certified laboratories will be kept alive as far as political decisions will allow us to. This may be subject to change (force majeure), updates will be provided as available.

We have been informed today that testing conducted at our partner-labs at the RWTH University of Aachen will be affected to a certain degree, as the local government may decide a shutdown for all Universities.

The team of ac.biomed is using its best efforts to communicate as soon as possible any influence this might have on the projects you are running with us.

We apologize that this situation is not in our hands, and we greatly appreciate your understanding and support of our fight to stop spreading of the virus. Let us contribute to save lives!

Our full team is available at least via eMail in their home-offices, so any of questions or concerns you want to share with us are welcome!

Sincerely yours, and good health to you and your families!

Peter Knipp
CEO

Meet the ac.biomed Team at the Transcatheter Cardiovascular Therapeutics (TCT) conference, this year in Miami.

For the first time we will participate at this year’s EuroElso conference in London! EuroELSO is the European branch of the Extracorporeal Life Support Organization (ELSO).

Visit our booth and discuss with our staff the latest developments in our testing field.

Meet our Staff Members this Year at the ESAO Congress in Hannover (03.-07.09.19) and at TCT in San Francisco (25.-29.09.19).

Visit our booth at this years TCT in San Diego. Talk to our staff about our latest developments in heart valve testing.

We are presenting newest achievements in heart valve testing and our recent portfolio of world class laboratory services.

It would be a pleasure for us to meet you!

Come and meet us in booth #4031 on the 2017 TCT in Denver

For the third time in a row ac.biomed will exhibit on the Transcatheter Cardiovascular Therapeutics (TCT) meeting organized by the Cardiovascular research Foundation. This year it will be held in Denver, Colorado (October 29 – November 2). Discuss with our staff on how we can help you to get your product the best way tested.

Follow us on the social networking websites LinkedIn and XING to get directly all the News from ac.biomed!

www.linkedin.com

www.xing.com

ac.biomed is exhibiting again on this year’s TCT in Washington DC, October 29th to November 2nd, 2016.

Visit our booth #1560 to meet and talk to our testing.experts. Transcatheter Cardiovascular Therapeutics (TCT) is the world’s largest and most important educational meeting specializing in interventional cardiovascular medicine.